These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Profound infantile neuroretinal dysfunction in a heterozygote for the CLN3 genetic defect. de los Reyes E; Dyken PR; Phillips P; Brodsky M; Bates S; Glasier C; Mrak RE J Child Neurol; 2004 Jan; 19(1):42-6. PubMed ID: 15032383 [TBL] [Abstract][Full Text] [Related]
8. Juvenile neuronal ceroid lipofuscinosis (Batten disease) CLN3 mutation (Chrom 16p11.2) with different phenotypes in a sibling pair and low intensity in vivo autofluorescence. Mantel I; Brantley MA; Bellmann C; Robson AG; Holder GE; Taylor A; Anderson G; Moore AT Klin Monbl Augenheilkd; 2004 May; 221(5):427-30. PubMed ID: 15162299 [TBL] [Abstract][Full Text] [Related]
11. Genetic linkage analysis of a variant of juvenile onset neuronal ceroid lipofuscinosis with granular osmiophilic deposits. O'Rawe A; Mitchison HM; Williams R; Wheeler R; Andermann E; Andermann F; Hart YM; Martin JJ; Philippart M; Stephenson JB; Gardiner RM; Mole SE Neuropediatrics; 1997 Feb; 28(1):21-2. PubMed ID: 9151314 [TBL] [Abstract][Full Text] [Related]
12. Full-field ERG in patients with Batten/Spielmeyer-Vogt disease caused by mutations in the CLN3 gene. Eksandh LB; Ponjavic VB; Munroe PB; Eiberg HE; Uvebrant PE; Ehinger BE; Mole SE; Andréasson S Ophthalmic Genet; 2000 Jun; 21(2):69-77. PubMed ID: 10916181 [TBL] [Abstract][Full Text] [Related]
13. Novel CLN3 mutation predicted to cause complete loss of protein function does not modify the classical JNCL phenotype. Kwon JM; Rothberg PG; Leman AR; Weimer JM; Mink JW; Pearce DA Neurosci Lett; 2005 Oct; 387(2):111-4. PubMed ID: 16087292 [TBL] [Abstract][Full Text] [Related]
14. A novel c.1135_1138delCTGT mutation in CLN3 leads to juvenile neuronal ceroid lipofuscinosis. Drack AV; Miller JN; Pearce DA J Child Neurol; 2013 Sep; 28(9):1112-6. PubMed ID: 23877479 [TBL] [Abstract][Full Text] [Related]
15. Genomic structure and complete nucleotide sequence of the Batten disease gene, CLN3. Mitchison HM; Munroe PB; O'Rawe AM; Taschner PE; de Vos N; Kremmidiotis G; Lensink I; Munk AC; D'Arigo KL; Anderson JW; Lerner TJ; Moyzis RK; Callen DF; Breuning MH; Doggett NA; Gardiner RM; Mole SE Genomics; 1997 Mar; 40(2):346-50. PubMed ID: 9119403 [TBL] [Abstract][Full Text] [Related]
16. Protracted course of juvenile ceroid lipofuscinosis associated with a novel CLN3 mutation (p.Y199X). Sarpong A; Schottmann G; Rüther K; Stoltenburg G; Kohlschütter A; Hübner C; Schuelke M Clin Genet; 2009 Jul; 76(1):38-45. PubMed ID: 19489875 [TBL] [Abstract][Full Text] [Related]
17. Investigation of Batten disease with the yeast Saccharomyces cerevisiae. Pearce DA; Sherman F Mol Genet Metab; 1999 Apr; 66(4):314-9. PubMed ID: 10191120 [TBL] [Abstract][Full Text] [Related]
18. The subcellular location of the yeast Saccharomyces cerevisiae homologue of the protein defective in the juvenile form of Batten disease. Croopnick JB; Choi HC; Mueller DM Biochem Biophys Res Commun; 1998 Sep; 250(2):335-41. PubMed ID: 9753630 [TBL] [Abstract][Full Text] [Related]